Institute Scholar Peter Kim, in collaboration with the Stanford IMA, developed a new therapeutic design that can broadly & potently neutralize a wide spectrum of betacoronaviruses, offering a potential solution to treating rapidly evolving viruses like SARS-CoV-2:
Development of ACE2-tropic-betacoronavirus therapeutics for future pandemic preparedness
Developing treatments that withstand viral evolution is difficult. Here, the authors design ReconnAb-multimers: broad, highly potent therapeutics linking a non-neutralizing antibody, ACE2, and a multimerization...
